Booth Preview

Article

Topical Dermatological Formulation Experience - Since 1977, Dow has focused exclusively on topicals and has developed more Rx topical formulations than any other company in the world.
Experience With a Broad Range of Indications and Dosage Forms - Dow has developed topical formulations for psoriasis, acne, atopic dermatitis, actinic keratosis, rosacea, wrinkles, fungal infections, women’s health, topical pain, wound healing, warts and other dermatological conditions.
One-Stop Shop - All services needed to progress your topical formulation through development, testing, manufacturing, labeling and delivery to clinical sites are available at our facility in Petaluma, California.
Topical Dermatological Formulation Experience - Since 1977, Dow has focused exclusively on topicals and has developed more Rx topical formulations than any other company in the world.
Experience With a Broad Range of Indications and Dosage Forms - Dow has developed topical formulations for psoriasis, acne, atopic dermatitis, actinic keratosis, rosacea, wrinkles, fungal infections, women’s health, topical pain, wound healing, warts and other dermatological conditions.
One-Stop Shop - All services needed to progress your topical formulation through development, testing, manufacturing, labeling and delivery to clinical sites are available at our facility in Petaluma, California.

Topical Formulations Development

Topical Product Development Consulting Services

In Vitro Drug Permeation Studies

Labeling, Packaging & Distribution of Clinical Supplies

Clinical Manufacturing

 
 
 
 
 
Contact Information
 
Dow Pharmaceutical Sciences, Inc.
 
• Tel: 707.793.2600 • Fax: 707.793.0145 •
Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content